Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Online applications...

    Online applications with CDSCO: DCGI issues clarification on fee submission

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-16T14:24:47+05:30  |  Updated On 16 March 2020 2:33 PM IST
    Online applications with CDSCO: DCGI issues clarification on fee submission

    New Delhi: Through a recent notice Central Drugs Standard Control Organization(CDSCO), Directorate General of Health Services has released a clarification for utilization of same fees in case of an inadvertent submission of online applications along with fees meant for a specific division submitted to other division of CDSCO.

    The clarification was given by Dr V G Somani, Drugs Controller General (India) (DCGI) through a notice on its website with a copy CDAC with a request to make appropriate system in Sugam Portal so that fees submitted in one division of CDSCO can be utilized by concerned division after the declaration of such inadvertent submission either by the applicant or by the division of CDSCO, HQ & publish the procedure.

    The applicants are required to submit their applications along with fees in different Divisions of this Directorate for obtaining various permissions/approvals. In this light the CDSCO noted

    It has been observed that many a time, an applicant submit their online applications inadvertently to a division/section not related to that application (e.g. New Drug Division, FDC Division, GCT Division, Import & Registration Division, etc.) Therefore, in order to ensure transparency, accountability & streamlining of the regulatory process for ease of doing business, it is to clarify that the fees paid for such application can be considered for submission and processing of that application in the related division of CDSCO, HQ after such application has been declared by applicant or CDSCO as inadvertent and not related to division applied for.

    For the full details, please click on the link given below:

    https://business.medicaldialogues.in/pdf_upload/pdf_upload-125473.pdf


    cdscoonline applicationfeessugam portal

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok